Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

April 07, 2015 06:00 ET | Source: Amarantus BioScience Holdings, Inc.

Amarantus Reports 2014 Financial Results and Business Overview

SAN FRANCISCO and GENEVA, April 7, 2015 (GLOBE NEWSWIRE) -- Amarantus BioScience Holdings, Inc. (OTCQB:AMBS), a biotechnology company focused on developing diagnostics in neurology, and therapeutic...
March 26, 2015 10:00 ET | Source: Amarantus BioScience Holdings, Inc.

Amarantus BioScience Opens Investigational New Drug (IND) Application With the U.S. Food and Drug Administration Allowing the Start of a Phase 2b Program of Eltoprazine in Parkinson's Disease Levodopa-Induced Dyskinesia

SAN FRANCISCO, March 26, 2015 (GLOBE NEWSWIRE) -- Amarantus BioScience Holdings, Inc. (OTCQB:AMBS), a biotechnology company focused on developing therapeutics and diagnostics in neurology, psychiatry,...
March 23, 2015 08:05 ET | Source: Amarantus BioScience Holdings, Inc.

Amarantus to Present at the Neurotech Investing and Partnering Conference on Tuesday, April 7, 2015

SAN FRANCISCO and GENEVA, March 23, 2015 (GLOBE NEWSWIRE) -- Amarantus BioSciences Holdings, Inc. (OTCQB:AMBS), a biotechnology company focused on developing diagnostics in neurology, and therapeutic...
February 23, 2015 08:30 ET | Source: Amarantus BioScience Holdings, Inc.

Amarantus to Present Positive Alzheimer's Disease Biomarker Data on the LymPro Test(R) at the 12th International Conference on Alzheimer's and Parkinson's Diseases and Related Neurological Disorders

SAN FRANCISCO and GENEVA, Feb. 23, 2015 (GLOBE NEWSWIRE) -- Amarantus BioSciences Holdings, Inc. (OTCQB:AMBS), a biotechnology company focused on developing diagnostics in neurology, and therapeutic...
February 18, 2015 11:00 ET | Source: Amarantus BioScience Holdings, Inc.

Amarantus Announces First Alzheimer's Biomarker Services Collaboration for LymPro Test(R) With Anavex Life Sciences Corp.

Investigational Alzheimer's drug candidate ANAVEX 2-73 and drug combination ANAVEX PLUS pharmacodynamic activity to be evaluated using Amarantus' LymPro Test® in blood samples from...
February 10, 2015 06:00 ET | Source: Amarantus BioScience Holdings, Inc.

Amarantus Announces Publication in BRAIN of Eltoprazine Phase 2a Clinical Study for Treating Parkinson's Disease Levodopa-Induced Dyskinesia

Eltoprazine demonstrated significant beneficial anti-dyskinesia effect at 5 and 7.5 mg doses, with no reduction of levodopa efficacy Eltoprazine was well tolerated at all dose levels, with...
February 03, 2015 08:05 ET | Source: Amarantus BioScience Holdings, Inc.

Amarantus to Present at the 17th Annual BIO CEO & Investor Conference on February 10, 2015

SAN FRANCISCO and GENEVA, Feb. 3, 2015 (GLOBE NEWSWIRE) -- Amarantus BioScience Holdings, Inc. (OTCQB:AMBS), a biotechnology company focused on developing diagnostics in neurology, and therapeutic...
January 22, 2015 07:00 ET | Source: Amarantus BioScience Holdings, Inc.

Amarantus Forms Alzheimer's Disease Diagnostics Scientific Advisory Board

SAN FRANCISCO and GENEVA, Jan. 22, 2015 (GLOBE NEWSWIRE) -- Amarantus BioScience Holdings, Inc. (OTCQB:AMBS), a biotechnology company focused on developing diagnostics in neurology, and therapeutic...
January 15, 2015 06:15 ET | Source: Amarantus BioScience Holdings, Inc.

Amarantus Announces Exclusive Option Agreement With Georgetown University to License Patent Rights for Blood Based Biomarkers for Alzheimer's Disease

SAN FRANCISCO and GENEVA, Jan. 15, 2015 (GLOBE NEWSWIRE) -- Amarantus BioScience Holdings, Inc. (OTCQB:AMBS), a biotechnology company focused on the development of novel diagnostic tests in neurology...
January 15, 2015 06:00 ET | Source: Amarantus BioScience Holdings, Inc.

Amarantus Announces Positive Data From 140 Subject LP-002 Clinical Study of LymPro Test(R) Confirming Statistically Significant Markers for Alzheimer's

SAN FRANCISCO and GENEVA, Jan. 15, 2015 (GLOBE NEWSWIRE) -- Amarantus BioScience Holdings, Inc. (OTCQB: AMBS), a biotechnology company focused on the development of diagnostics for neurology and...